Halomine Inc.

Ithaca, NY · Medtech · Still private

HaloFilm, a spray-on antimicrobial polymer coating that forms a chlorine-releasing film on surfaces to prevent healthcare-associated infections

New patent · Oct 20

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · halomine.com

Sector: Medtech
Headquarters: Ithaca, NY
Total capital: $8.9M

Federal grants: $8.9M; 17 awards · 2020–2025; Rank in peer group#12 of 36
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 1; 8 pending · first 2026; Rank in peer group#9 of 36

Capital timeline

Latest events

Sep 2025Federal grantHealth and Human S · Phase I · Novel, bio-inspired chloramine for infection eradication in chronic wounds$348K
Aug 2025Federal grantHealth and Human S · Phase II · Novel, low corrosion, bio-compatible disinfectant with biofilm and residual efficacy$992K
Jul 2025Federal grantHealth and Human S · Phase I · Novel, bio-inspired chloramine to treat cutaneous fungal infections without resistance generation potential$299K
Jun 2024Federal grantHealth and Human S · Phase I · Novel Polymer Additives for Infection Control Intravenous Catheters$295K
Nov 2023Federal grantHealth and Human S · Phase II · HaloFilm: a spray-on, re-chargeable, re-applicable antimicrobial coating$744K
Jun 2023Federal grantHealth and Human S · Phase I · Non-coating anti-microbial, anti-host protein deposition, anti-inflammatory urinary catheter$325K
Jun 2023Federal grantHealth and Human S · Phase I · Non-coating anti-microbial, anti-host protein deposition, anti-inflammatory urinary catheter$325K

Show 10 earlier federal awards

Dec 2022Federal grantHealth and Human S · Phase II · HaloFilm: a spray-on, re-chargeable, re-applicable antimicrobial coating$1M
Dec 2022Federal grantHealth and Human S · Phase II · HaloFilm: a spray-on, re-chargeable, re-applicable antimicrobial coating$1M
Jul 2022Federal grantAgriculture · Food Safety Is A Priority Goal For The Usda Nifa SBIR Program And The Food Industry For Obvious Food Security, Public Health, And Economic Reasons. Hazard Analysis And Critical Control Points (haccp) Systems Have Been Implemented Industry Wide To Manage Operational Disinfecting And Cleaning, But These Approaches Are Not Infallible. Technical Solutions Are Needed That Can Enhance Current Systems And Reduce Risk Of Food-borne Illness. Because Modular Conveyor Belts Represent The Second Most Prolif$175K
Sep 2021Federal grantNSF · Phase II · SBIR Phase II: An adjuvant-based antimicrobial coating (COVID-19)$1.7M
Sep 2020Federal grantAgriculture · Forty-eight Million People Suffer From Foodborne Illnesses Every Year And 3,000 People Die. While The Human Cost Is Immense And Tragic, The Cost To Food Companies Can Be Equally Steep. The Average Cost Of A Recall For Food Processors Can Be As Much As $10 Million In Direct Costs, And, Even Worse, Result In 50% Drop In Sales For The First Year. Some Food Processing Companies Have Been Completely Wiped Out. The Current Sanitation Protocols, Namely Daily Applications Of Short-lived Disinfectants, A$600K
Aug 2020Federal grantHealth and Human S · Phase I · HaloFilm: a spray-on, re-chargeable, re-applicable antimicrobial coating$250K
Aug 2020Federal grantHealth and Human S · Phase I · HaloFilm: a spray-on, re-chargeable, re-applicable antimicrobial coating$250K
Jul 2020Federal grantDefense · Phase I · Expeditionary Technology Search (xTechSearch) Dual-Use Technologies to solve challenging Army problems$100K
Jun 2020Federal grantNSF · Phase I · SBIR Phase I: HaloFilm as a virucide against COVID-19 infection$256K
May 2020Federal grantNSF · Phase I · SBIR Phase I: HaloFilm – a spray-on, rechargeable, reapplicable antimicrobial coating$225K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 36 peers

Line = median

Medtech · Material

Federal grants#12 · top 33%
Granted patents#9 · top 25%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 1 granted of 9

Oct 20, 2026New patentCompositions And Methods For Antimicrobial ArticlesUSPTOUS 12,765,553
Aug 21, 2025PendingDisinfectant Compositions And Methods ThereofUSPTOApplication 19196184
Jun 1, 2023PendingCompositions And Methods For Antimicrobial ArticlesUSPTOApplication 17981756

Show all 9 patent records

Compositions And Methods For Antimicrobial ArticlesOct 20, 2026 · US 12,765,553Granted
Disinfectant Compositions And Methods ThereofAug 21, 2025 · Application 19196184Pending
Compositions And Methods For Antimicrobial ArticlesJun 1, 2023 · Application 17981756Pending
Disinfectant Compositions And Methods ThereofApplication PCTUS2023033875Pending
Topical And Surface Disinfectant CompositionsApplication 63574203Pending
Compositions And Methods For Antimicrobial ArticlesApplication PCTUS2021032226Pending
Compositions And Methods For Antimicrobial ArticlesApplication 63025028Pending
Topical And Surface Disinfectant CompositionsApplication PCTUS2025023028Pending
Disinfectant Compositions And Methods ThereofApplication 63410380Pending

AdelaSimilar federal contract value in Medtech · null in contracts
CPR THERAPEUTICS INC.Similar federal contract value in Medtech · null in contracts
MARS Bioimaging LtdSimilar federal contract value in Medtech · null in contracts
NEOFLUIDICS, LLCSimilar federal contract value in Medtech · null in contracts
PathSpot Technologies, Inc.Similar federal contract value in Medtech · null in contracts
Pathr.ai, Inc.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.